Ontology type: schema:ScholarlyArticle Open Access: True
2022-04-04
AUTHORSRomans Zukovs, Christina Antke, Eduards Mamlins, Lino Morris Sawicki, Annemarie Mohring, David Lopez y Niedenhoff, Amelie Boquoi, Mustafa Kondakci, Gerald Antoch, Hans-Wilhelm Müller, Roland Fenk, Rainer Haas
ABSTRACTPurposeWhile 18F-FDG PET/CT yields valuable prognostic information for patients in first-line therapy of multiple myeloma (MM), its prognostic relevance in relapse is not established. Available studies of relapsed MM describe prognostic thresholds for frequently used PET/CT parameters that are significantly higher than those identified in the first-line setting. The purpose of this study was to evaluate the prognostic role of PET/CT in relapsed MM, based on parameters used in the first-line setting.MethodsOur retrospective study included 36 patients with MM who had received autologous or allogeneic stem cell transplantation, suffered at least one relapse, and underwent FDG-PET/CT at relapse. Number of focal bone lesions (FL), maximal standardised uptake value (SUVmax), and presence of PET-positive extramedullary lesions (EMD) were analysed.ResultsFor the number of FLs, the prognostic value was demonstrated with a cut-off of > 3 (median OS 3.8 months vs. not reached, p = 0.003). Median OS of patients with SUVmax ≤ 4 was not reached, while it was 3.9 months in patients with SUVmax > 4 (p = 0.014). Presence of EMD was a significant prognostic parameter too, with median OS of 3.6 months versus not reached (p = 0.004). The above-mentioned parameters showed prognostic significance for PFS as well. Combination of higher ISS stage and PET/CT parameters identified patients with particularly short OS (3.7 months vs. not reached, p < 0.001) and PFS (3.6 vs. 11.7 months p < 0.001).ConclusionThe PET/CT parameters SUVmax > 4, nFL > 3, and presence of EMD identify patients with poor prognosis not only in the first-line setting but also in relapsed MM. More... »
PAGES63
http://scigraph.springernature.com/pub.10.1186/s12880-022-00788-4
DOIhttp://dx.doi.org/10.1186/s12880-022-00788-4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1146867372
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/35379187
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Fluorodeoxyglucose F18",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Multiple Myeloma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Positron Emission Tomography Computed Tomography",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prognosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Zukovs",
"givenName": "Romans",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Clinic for Nuclear Medicine, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Clinic for Nuclear Medicine, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Antke",
"givenName": "Christina",
"id": "sg:person.01265666626.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265666626.78"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Clinic for Nuclear Medicine, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Clinic for Nuclear Medicine, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Mamlins",
"givenName": "Eduards",
"id": "sg:person.013411312775.27",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013411312775.27"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Sawicki",
"givenName": "Lino Morris",
"id": "sg:person.01115265121.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115265121.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Mohring",
"givenName": "Annemarie",
"id": "sg:person.07675625555.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07675625555.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Lopez y Niedenhoff",
"givenName": "David",
"id": "sg:person.011313350733.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011313350733.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Boquoi",
"givenName": "Amelie",
"id": "sg:person.0774513574.12",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774513574.12"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department for Oncology and Hematology, St. Lukas Clinic Solingen, 42697, Solingen, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department for Oncology and Hematology, St. Lukas Clinic Solingen, 42697, Solingen, Germany"
],
"type": "Organization"
},
"familyName": "Kondakci",
"givenName": "Mustafa",
"id": "sg:person.01150516001.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Antoch",
"givenName": "Gerald",
"id": "sg:person.01245267403.84",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245267403.84"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Clinic for Nuclear Medicine, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Clinic for Nuclear Medicine, Medical Faculty, Heinrich Heine University Dusseldorf, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "M\u00fcller",
"givenName": "Hans-Wilhelm",
"id": "sg:person.01121021524.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121021524.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Fenk",
"givenName": "Roland",
"id": "sg:person.01177747626.74",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177747626.74"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Dusseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Haas",
"givenName": "Rainer",
"id": "sg:person.01127414674.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00259-017-3730-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1085742586",
"https://doi.org/10.1007/s00259-017-3730-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00259-018-4114-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1106679470",
"https://doi.org/10.1007/s00259-018-4114-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-019-03852-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1122946267",
"https://doi.org/10.1007/s00277-019-03852-2"
],
"type": "CreativeWork"
}
],
"datePublished": "2022-04-04",
"datePublishedReg": "2022-04-04",
"description": "PurposeWhile 18F-FDG PET/CT yields valuable prognostic information for patients in first-line therapy of multiple myeloma (MM), its prognostic relevance in relapse is not established. Available studies of relapsed MM describe prognostic thresholds for frequently used PET/CT parameters that are significantly higher than those identified in the first-line setting. The purpose of this study was to evaluate the prognostic role of PET/CT in relapsed MM, based on parameters used in the first-line setting.MethodsOur retrospective study included 36 patients with MM who had received autologous or allogeneic stem cell transplantation, suffered at least one relapse, and underwent FDG-PET/CT at relapse. Number of focal bone lesions (FL), maximal standardised uptake value (SUVmax), and presence of PET-positive extramedullary lesions (EMD) were analysed.ResultsFor the number of FLs, the prognostic value was demonstrated with a cut-off of\u2009>\u20093 (median OS 3.8\u00a0months vs. not reached, p\u2009=\u20090.003). Median OS of patients with SUVmax\u2009\u2264\u20094 was not reached, while it was 3.9\u00a0months in patients with SUVmax\u2009>\u20094 (p\u2009=\u20090.014). Presence of EMD was a significant prognostic parameter too, with median OS of 3.6\u00a0months versus not reached (p\u2009=\u20090.004). The above-mentioned parameters showed prognostic significance for PFS as well. Combination of higher ISS stage and PET/CT parameters identified patients with particularly short OS (3.7\u00a0months vs. not reached, p\u2009<\u20090.001) and PFS (3.6 vs. 11.7\u00a0months p\u2009<\u20090.001).ConclusionThe PET/CT parameters SUVmax\u2009>\u20094, nFL\u2009>\u20093, and presence of EMD identify patients with poor prognosis not only in the first-line setting but also in relapsed MM.",
"genre": "article",
"id": "sg:pub.10.1186/s12880-022-00788-4",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1024948",
"issn": [
"1471-2342"
],
"name": "BMC Medical Imaging",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "22"
}
],
"keywords": [
"first-line setting",
"PET/CT",
"focal bone lesions",
"PET/CT parameters",
"first-line therapy",
"multiple myeloma",
"extramedullary lesions",
"prognostic threshold",
"CT parameters",
"allogeneic stem cell transplantation",
"FDG PET/CT",
"stem cell transplantation",
"maximal standardised uptake value",
"significant prognostic parameter",
"valuable prognostic information",
"standardised uptake value",
"MethodsOur retrospective study",
"median OS",
"median OS",
"ISS stage",
"shorter OS",
"prognostic role",
"retrospective study",
"prognostic value",
"prognostic significance",
"poor prognosis",
"prognostic relevance",
"cell transplantation",
"prognostic parameters",
"prognostic information",
"bone lesions",
"patients",
"uptake value",
"relapse",
"SUVmax",
"CT",
"available studies",
"myeloma",
"therapy",
"PFS",
"lesions",
"months",
"setting",
"transplantation",
"prognosis",
"PurposeWhile",
"study",
"NfL",
"presence",
"OS",
"threshold",
"significance",
"role",
"number",
"relevance",
"stage",
"combination",
"purpose",
"values",
"parameters",
"information"
],
"name": "18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?",
"pagination": "63",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1146867372"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s12880-022-00788-4"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"35379187"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s12880-022-00788-4",
"https://app.dimensions.ai/details/publication/pub.1146867372"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:12",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_935.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/s12880-022-00788-4"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12880-022-00788-4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12880-022-00788-4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12880-022-00788-4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12880-022-00788-4'
This table displays all metadata directly associated to this object as RDF triples.
238 TRIPLES
21 PREDICATES
94 URIs
83 LITERALS
13 BLANK NODES